AbbVie, Allergan deal approved in Taiwan
( November 20, 2019, 09:37 GMT | Official Statement) -- MLex Summary: The proposed $63 billion acquisition of Dublin-based pharmaceutical company Allergan by Chicago-based AbbVie has been approved by the Taiwan Fair Trade Commission today, the regulator said in a statement. The regulator said the transaction won't change the structure of the relevant markets in Taiwan.不禁止美商AbbVie Inc.、美商Venice Subsidiary LLC及愛爾蘭商Allergan plc結合案。...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.